RFP(지원분야)

발표평가 대상과제-과제번호

(1내역)

신약 기반 확충 연구

유효물질단계

RS-2024-00332326

RS-2024-00334337

RS-2024-00337810

RS-2024-00332469

RS-2024-00335752

RS-2024-00338049

RS-2024-00332509

RS-2024-00335757

RS-2024-00338112

RS-2024-00332641

RS-2024-00336417

RS-2024-00338220

RS-2024-00332803

RS-2024-00336646

RS-2024-00338343

RS-2024-00333050

RS-2024-00336938

RS-2024-00338537

RS-2024-00333164

RS-2024-00337233

RS-2024-00333761

RS-2024-00337736

선도물질단계

RS-2024-00332235

RS-2024-00335267

RS-2024-00337284

RS-2024-00332392

RS-2024-00336018

RS-2024-00337392

RS-2024-00332418

RS-2024-00336130

RS-2024-00337468

RS-2024-00332552

RS-2024-00336725

RS-2024-00337757

RS-2024-00332895

RS-2024-00336837

RS-2024-00337783

RS-2024-00332957

RS-2024-00336957

RS-2024-00338105

RS-2024-00333055

RS-2024-00336979

RS-2024-00338745

RS-2024-00333128

RS-2024-00337083

RS-2024-00338805

(2내역)

신약 R&D 생태계 구축 연구

후보물질단계

RS-2024-00332252

RS-2024-00333140

RS-2024-00337290

RS-2024-00332328

RS-2024-00334041

RS-2024-00337759

RS-2024-00332483

RS-2024-00334382

RS-2024-00337767

RS-2024-00332710

RS-2024-00334706

RS-2024-00338017

RS-2024-00332806

RS-2024-00335953

RS-2024-00338030

RS-2024-00332854

RS-2024-00336489

RS-2024-00338163

RS-2024-00332991

RS-2024-00337005

RS-2024-00338204

RS-2024-00333115

RS-2024-00337033

RS-2024-00338363

비임상단계

RS-2024-00332248

RS-2024-00335807

RS-2024-00337146

RS-2024-00332960

RS-2024-00336133

RS-2024-00337888

RS-2024-00333652

RS-2024-00336376

RS-2024-00338382

RS-2024-00334310

RS-2024-00336377

RS-2024-00338386

RS-2024-00335317

RS-2024-00336882

RS-2024-00338747

(3내역)

신약 임상개발

임상단계

(임상1상, 임상2상)

RS-2024-00332242

RS-2024-00332815

RS-2024-00336505

RS-2024-00332279

RS-2024-00333053

RS-2024-00337081

RS-2024-00332313

RS-2024-00333386

RS-2024-00337222

RS-2024-00332434

RS-2024-00335179

RS-2024-00338035

RS-2024-00332473

RS-2024-00336107

RS-2024-00338214

이메일

연락처

kddf_pm@kddf.org

02-6379-3083